Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

(2015) William M. Sikov et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity

(2015) Lavinia Raimondi et al.   Oncotarget

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)†

(2014) G. von Minckwitz et al.   ANNALS OF ONCOLOGY

Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho

(2014) Xu-Jun He et al.   BMC CANCER

SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer

(2014) X Zhao et al.   CELL DEATH AND DIFFERENTIATION

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation

(2014) P. Gasparini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries

(2013) Clare TM Lai et al.   BMC Cardiovascular Disorders

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

(2013) I Shapira et al.   BRITISH JOURNAL OF CANCER

microRNAs in breast cancer development and treatment

(2013) Danila Serpico et al.   CANCER TREATMENT REVIEWS

Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells

(2013) Heqing Yi et al.   FEBS LETTERS

Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes

(2013) Yanling Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer

(2013) Rui-chao Zeng et al.   MEDICAL ONCOLOGY

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

(2013) Luciano Cascione et al.   PLoS One

Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

(2013) Enders K. O. Ng et al.   PLoS One

Triple-negative breast cancer: epidemiological considerations and recommendations

(2012) P. Boyle   ANNALS OF ONCOLOGY

Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls

(2012) Zhibin Hu et al.   CARCINOGENESIS

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

(2012) Otto Metzger-Filho et al.   JOURNAL OF CLINICAL ONCOLOGY

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

(2012) Lisa A. Carey et al.   JOURNAL OF CLINICAL ONCOLOGY

miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer

(2012) S-F Su et al.   ONCOGENE

Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells

(2012) Syreeta L. Tilghman et al.   PLoS One

PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

(2012) Yasir H. Ibrahim et al.   Cancer Discovery

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

(2011) Eunjung Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating microRNAs in plasma of patients with gastric cancers

(2010) M Tsujiura et al.   BRITISH JOURNAL OF CANCER

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells

(2010) Mineko Terao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

(2010) Daniel P. Silver et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

(2009) E K O Ng et al.   GUT

Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

(2008) Stephen Kalscheuer et al.   CARCINOGENESIS

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA